Search

Search Constraints

You searched for: Author/Creator Curiel, Tyler J.

Search Results

1. Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer. (2nd November 2018)

2. Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy. (24th February 2021)

3. Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice. Issue 6 (28th August 2015)

4. Immune checkpoint expression and relationships to anti‐PD‐L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice. Issue 1 (25th February 2022)

5. Interventions to Slow Aging in Humans: Are We Ready?. Issue 4 (22nd April 2015)

8. Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial. (3rd August 2019)